Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
28,600
-500 (-1.72%)
Apr 2, 2026, 3:30 PM KST
Market Cap168.17B +12.8%
Revenue (ttm)208.61B +2.2%
Net Income27.64B -18.1%
EPSn/a
Shares Out5.88M
PE Ratio6.08
Forward PE5.11
Dividend900.00 (3.09%)
Ex-Dividend DateDec 29, 2025
Volume16,107
Average Volume12,493
Open29,150
Previous Close29,100
Day's Range28,250 - 29,300
52-Week Range24,750 - 33,950
Beta0.19
RSI44.09
Earnings DateMay 15, 2026

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2025, Daihan Pharmaceutical's revenue was 208.61 billion, an increase of 2.16% compared to the previous year's 204.19 billion. Earnings were 27.64 billion, a decrease of -18.11%.

Financial Statements